Eduardo Canto

Appearances

ROBOTIC AND MINIMALLY INVASIVE ESOPHAGECTOMY AND NEOADJUVANT TREATMENT RELATED DOWNSTAGING ARE ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN PATIENTS WITH ESOPHAGEAL ADENOCARCINOMA: A NATIONAL CANCER DATABASE STUDY (NCDB)
Date
May 19, 2024
Esophageal adenocarcinoma (EAC) has been associated with poor survival, with an estimated median survival of 15 months. Neoadjuvant chemoradiation (NCRT) followed by esophagectomy is considered the standard of care for locally advanced EAC…
Presenter
Eduardo Canto
Speakers
Matthew Reilly
Alexander Hall
Ryan Walters
Kalyana Nandipati